GENE ONLINE|News &
Opinion
Blog

Merck
R&D CAR-T Technology
First Non-Gene Edited CAR-T to Partner with Merck’s Blockbuster Against Colorectal Cancer
2020-10-01
Trials & Approvals
#ESMO20: AZ, Merck’s PARP Inhibitor Surpasses Standard of Care in Prostate Cancer Trial
2020-09-22
R&D
Merck Bets Big on Seattle Genetics for Two Oncology Drugs
2020-09-16
Trials & Approvals ESCC
Keytruda Receives Two New Approvals in Japan
2020-08-30
Trials & Approvals Pancreatic Cancer
Lynparza Notches EU Authorization for BRCA-Mutated Metastatic Pancreatic Cancer
2020-07-11
Trials & Approvals Anti-HIV-1
Merck Reports Higher Efficacy for Islatravir Doravirine Combo in Adults with HIV-1 Infection
2020-07-09
Trials & Approvals Pneumococcal Vaccine
Merck’s Pneumonia Vaccine Candidate Blossoms in Phase 3 Trial
2020-06-28
Trials & Approvals Cancer
Keytruda Wins Big in China, Now Approved for Esophageal Squamous Cell Carcinomas
2020-06-26
COVID-19
BIO Digital 2020 Highlights: Global Solutions for Implementation: From Scale-up to Worldwide Access
2020-06-24
Trials & Approvals Pneumonia
FDA Okays Merck ‘s Combination Antibiotic for Hospital-Acquired Bacterial Pneumonia
2020-06-12
R&D
ASCO 2020: Keytruda Shines as New Quality of Care in Treating metastatic Colorectal Cancer
2020-06-03
Technology
AACR 2020 – Changing the Immunotherapy Paradigm
2020-05-08
R&D
AACR 2020 Conference – Advances in the Field of Lung Cancer Targeted Therapies
2020-04-28
R&D Lung Cancer
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
In-Depth TIGIT Receptor
TIGIT Immunotherapy: A Ray of Hope for Cancer Treatment?
2020-04-04
1 … 3 4 5 6 7
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top